4//SEC Filing
Johnson Marvin 4
Accession 0001415889-25-001928
CIK 0001267813other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:16 PM ET
Size
5.1 KB
Accession
0001415889-25-001928
Insider Transaction Report
Form 4
Johnson Marvin
Director
Transactions
- Sale
Common Stock
2025-01-21$0.54/sh−1,610$869→ 12,490 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the "Company") sold by the reporting person pursuant to a Rule 10b5-1 Plan adopted on March 10, 2024 to cover tax obligations in connection with the vesting of restricted stock units.
Documents
Issuer
MARINUS PHARMACEUTICALS, INC.
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001852752
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:16 PM ET
- Size
- 5.1 KB